Incidence and risk factors for thrombosis in patients with acute promyelocytic leukemia. experience of the PETHEMALPA96 and LPA99 protocols.

被引：18
|
作者：
Montesinos, Pau
de la Serna, Javier
Vellenga, Edo
Rayon, Consuelo
Bergua, Juan
Parody, Ricardo
Esteve, Jordi
Gonzalez, Marcos
Brunet, Salud
Sanz, Miguel
机构：
[1] Hosp La Fe, E-46009 Valencia, Spain
[2] Hosp 12 Octubre, Madrid, Spain
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.1503.1503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1503
引用
收藏
页码：434A / 434A
页数：1
相关论文
共 20 条
  • [1] Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99):: benefit of an early intervention
    Esteve, J.
    Escoda, L.
    Martin, G.
    Rubio, V.
    Diaz-Mediavilla, J.
    Gonzalez, M.
    Rivas, C.
    Alvarez, C.
    San Miguel, J. D. Gonzalez
    Brunet, S.
    Tomas, J. F.
    Tormo, M.
    Sayas, M. J.
    Godoy, P. Sanchez
    Colomer, D.
    Bolufer, P.
    Sanz, M. A.
    LEUKEMIA, 2007, 21 (03) : 446 - 452
  • [2] Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention
    J Esteve
    L Escoda
    G Martín
    V Rubio
    J Díaz-Mediavilla
    M González
    C Rivas
    C Álvarez
    J D González San Miguel
    S Brunet
    J F Tomás
    M Tormo
    M J Sayas
    P Sánchez Godoy
    D Colomer
    P Bolufer
    M A Sanz
    Leukemia, 2007, 21 : 446 - 452
  • [3] Risk-adapted treatment of acute promyelocytic leukemia: Updated results of the Spanish PETHEMA LPA99 Trial using ATRA and anthracycline monochemotherapy.
    Sanz, MA
    Martin, G
    Vellenga, E
    Bolufer, P
    Gonzalez, M
    Rayon, C
    de la Serna, J
    Parody, R
    Bergua, J
    Negri, S
    Rivas, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 563S - 563S
  • [4] Incidence of retinoic acid syndrome during induction therapy for acute promyelocytic leukemia (pethema protocols LPA 96 &9 99) reveals two peaks with different induction mortality
    Bergua, J. M.
    Montesinos, P.
    Guillermo, G.
    De la Serna, J.
    Vallenga, E.
    Rayon, C.
    Esteve, J.
    Gonzalez, M.
    Gonzalez, J.
    Brunet, S.
    Sanzz, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 146 - 147
  • [5] Outcome of patients with acute promyelocytic leukemia failing to treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA 96 & 99).
    Esteve, J
    Escoda, L
    Martín, G
    Debén, G
    Díaz-Mediavilla, J
    León, A
    de la Serna, J
    Amutio, E
    González, M
    Tormo, M
    Capote, FJ
    Novo, A
    Bolufer, P
    Chillón, C
    González, J
    Colomer, D
    Bergua, JM
    Sanz, MA
    BLOOD, 2002, 100 (11) : 343A - 343A
  • [6] Arterial Thrombosis in Patients with Acute Myeloid Leukemia: Incidence and Risk Factors
    Mitrovic, Mirjana
    Pantic, Nikola
    Sabljic, Nikica
    Bukumiric, Zoran
    Virijevic, Marijana
    Pravdic, Zlatko
    Cvetkovic, Mirjana
    Rajic, Jovan
    Bodrozic, Jelena
    Milosevic, Violeta
    Todorovic-Balint, Milena
    Vidovic, Ana
    Suvajdzic-Vukovic, Nada
    Antic, Darko
    CANCERS, 2023, 15 (11)
  • [7] Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
    Marta Sobas
    Wanda Knopinska-Posluszny
    Beata Piątkowska-Jakubas
    Flor García-Álvarez
    María Elena Amutio Díez
    Mar Caballero
    David Martínez-Cuadrón
    Eliana Aguiar
    Jose González-Campos
    Ana Garrido
    Lorenzo Algarra
    Olga Salamero
    Javier de la Serna
    Maria Jose Sayas
    Manuel Mateo Perez-Encinas
    Susana Vives
    Belén Vidriales
    Jorge Labrador
    Ana Inés Prado
    Lucía Celebrin
    Jiri Mayer
    Joana Brioso
    Almudena de Laiglesia
    Juan Miguel Bergua
    Maria Luz Amigo
    Carlos Rodriguez-Medina
    Marta Polo
    Agnieszka Pluta
    Edyta Cichocka
    Marek Skarupski
    Miguel A Sanz
    Agnieszka Wierzbowska
    Pau Montesinos
    Annals of Hematology, 2024, 103 : 451 - 461
  • [8] Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
    Sobas, Marta
    Knopinska-Posluszny, Wanda
    Piatkowska-Jakubas, Beata
    Garcia-Alvarez, Flor
    Diez, Maria Elena Amutio
    Caballero, Mar
    Martinez-Cuadron, David
    Aguiar, Eliana
    Gonzalez-Campos, Jose
    Garrido, Ana
    Algarra, Lorenzo
    Salamero, Olga
    de la Serna, Javier
    Sayas, Maria Jose
    Perez-Encinas, Manuel Mateo
    Vives, Susana
    Vidriales, Belen
    Labrador, Jorge
    Prado, Ana Ines
    Celebrin, Lucia
    Mayer, Jiri
    Brioso, Joana
    de Laiglesia, Almudena
    Bergua, Juan Miguel
    Amigo, Maria Luz
    Rodriguez-Medina, Carlos
    Polo, Marta
    Pluta, Agnieszka
    Cichocka, Edyta
    Skarupski, Marek
    Sanz, Miguel A.
    Wierzbowska, Agnieszka
    Montesinos, Pau
    ANNALS OF HEMATOLOGY, 2024, 103 (02) : 451 - 461
  • [9] Additional chromosome abnormalities have no prognostic value in acute promyelocytic leukemia patients treated with simultaneous ATRA and anthracycline-based chemotherapy:: An update of the APL96 and APL99 pethema protocols.
    Cervera, J
    Martin, G
    Hernandez, JM
    Vellenga, E
    Calasanz, MJ
    Martinez-Climent, JA
    Luño, E
    Ferro, MT
    Rayon, C
    Gonzalez, M
    Tormo, M
    Rivas, C
    Amutio, E
    de la Serna, J
    Gonzalez-San Miguel, JD
    Bergua, J
    Leon, A
    Diaz-Mediavilla, J
    Garcia-Laraña, J
    Esteve, J
    Sanz, MA
    BLOOD, 2004, 104 (11) : 557A - 557A
  • [10] Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia - a single center experience in 34 patients
    Dally, N
    Hoffman, R
    Haddad, N
    Sarig, G
    Rowe, JM
    Brenner, B
    THROMBOSIS RESEARCH, 2005, 116 (02) : 109 - 114
12